Navigation Links
Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
Date:11/4/2007

bert A. Harrington, M.D., Professor of Medicine, Duke University Medical Center, and Director, Duke Clinical Research Institute. "I'm looking forward to seeing data from phase II and phase III studies with the REG1 drug:antidote system."

"The data from the Phase 1c study addressed important questions, particularly regarding the ability to titrate the RB007 component and therefore 'dial down' the anticoagulant effect of RB006," stated Doug Gooding, Chief Executive Officer of Regado Biosciences. "Based upon our Phase I study results, we developed an extensive Phase II program to evaluate REG1 in a variety of coronary revascularization settings. The first study is actively enrolling patients and we expect to initiate several additional studies over the coming months."

REVERSAL-PCI, a multi-center, open-label, randomized Phase IIa clinical study of the REG1 anticoagulation system, will enroll 26 patients undergoing elective percutaneous coronary intervention (PCI) to assess whether REG1 can replace standard heparin therapy during the performance of coronary balloon angioplasty dilatation and stenting in patients at low risk for complications associated with therapy-related bleeding or heart attack.

About REG1 Anticoagulation System

Regado's lead product candidate, REG1, is the first specific, direct- acting, antidote-controlled anticoagulant ever described. Regado is developing REG1 for use in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures. These procedures, which include coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), put patients at a high-risk for therapy-related bleeding complications. REG1 is being developed initially to increase therapeutic flexibility and improve patient outcomes in coronary revascularization procedures.

REG1 is a two-component system, consisting of an aptamer-based anticoagulant and its matched antidote. The REG1 anticoagulant co
'/>"/>

SOURCE Regado Biosciences
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. Neurocrine Biosciences Announces New Research Studies Presented at APSS Reveal Significant Under-Diagnosis of Insomnia
5. Hana Biosciences Presents Data On Two Programs At the American Society of Clinical Oncology Annual Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. Lux Biosciences Investigational Therapy for Uveitis, LX211, is Subject of Two Presentations at Key Ophthalmology Meeting, ARVO 2007
9. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
10. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
11. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... 2014 ... has announced the addition of the  ... Automated External Defibrillators (AED) Market"  report ... ,The report North American Automated External ... of devices based upon following sub-segments ...
(Date:10/17/2014)... Oct. 17, 2014  Talyst, a market leader in ... Annual Meeting in Nashville, TN. ... market leading solution for onsite, remote medication dispensing. ... facilities to safely and securely dispense medication onsite, on ... dose, helps ensure that the correct medication gets to ...
(Date:10/17/2014)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" ... biopharmaceutical company in China , ... from the China Food and Drug Administration (the ... concentrate ("PCC") at its Shandong Taibang facility. The ... facility for Good Manufacturing Practices ("GMP") compliance in ...
Breaking Medicine Technology:Micro Market Monitor : North American Automated External Defibrillators (AED) Market 2Talyst Exhibits at LeadingAge Annual Meeting 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... 14, 2011 Micross Components, a leading global ... as General Manager of its US Products & ... product and business development, will play a leading ... its offerings to increase market share across several ...
... YORK and JERUSALEM, Sept. 14, 2011 Chiasma, Inc., a ... & CEO, will present an overview of the Company at ... New York, New York, on Monday, September 19, 2011 at ... an oral form of octreotide acetate being developed first for ...
Cached Medicine Technology:Micross Components Names Mike Deley as General Manager of US Products & Services Division 2Chiasma to Present at the UBS Global Life Sciences Conference 2
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Houston plastic ... present the key elements of his innovative True ... to plastic surgery residents and faculty at The ... where he, too, was once a medical student. Patronella, ... largest private cosmetic plastic surgery practices in Texas, ...
(Date:10/19/2014)... 20, 2014 Recently, BambooIndustry.com, one of ... its new range of bamboo deckings . Moreover, ... natural items; they are now available at deeply discounted ... it is hard to overstate the significance of online ... to online services. The company’s workers are striving to ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 Recently, ... and announced that JustHost, GoDaddy and HostMonster are ... market. VPS (Virtual Private Server) is the method ... servers, each of which has the appearance and ... That is why the site pays close attention ...
(Date:10/19/2014)... 2014 Stephen T. Greenberg, M.D., with offices ... the 10th consecutive year as one of Long Island’s best ... also been nominated as the best provider for Botox injections. ... best Day Spa and best Laser Treatment center on Long ... readers can vote for the contest once per day, per ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2Health News:High Quality Bamboo Deckings, New Items Unveiled By BambooIndustry.com 2Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Dr. Stephen T. Greenberg – Nominated for the 10th Consecutive Year for One of Long Island’s Best Cosmetic Surgeons for 2015 by the Long Island Press 2
... American Society of Hypertension, Inc. (ASH) today announced the ... related cardiovascular disease -- the ASH Hypertension Accreditation Program ... health professionals and pharmaceutical sales representatives. While this rigorous ... needs of each of the intended target groups, it ...
... 22 Medifast, Inc. (NYSE: MED ) announced today ... for the period ended March 31, 2009 on Wednesday, April 29, ... hold a conference call and web cast to discuss the results ... access the call by dialing (877) 407-0782 or (201) 689-8567, or ...
... little evidence for transfusions improving healthMILWAUKEE, Wis., April 22 ... literature by a panel of experts at the International ... (ICCTO) held this month in Phoenix concluded that ... from the greatest number of transfusions currently being given ...
... AcelRx Pharmaceuticals, Inc. today announced that it ... ARX-02, a proprietary sublingual sufentanil NanoTab(TM) product candidate ... of this multicenter, randomized, placebo-controlled, crossover study is ... relative to placebo in cancer patients experiencing episodic ...
... American Fertility Association,s Infertility Prevention ProgramNEW YORK, April 22 ... have difficulty conceiving, but many of those cases could ... changes. Education is the key and what better way ... infertility robs women of control over their own lives. ...
... Holly of the California Superior Court for San Joaquin County certified a ... Viking Industries. , ... Los Angeles, California (Lexis Nexis) April 22, 2009 ... the California Superior Court for San Joaquin County certified a Class ...
Cached Medicine News:Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 2Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 3Health News:The American Society of Hypertension Launches Education Program for Hypertension Accreditation 4Health News:Medifast, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Wednesday, April 29, 2009 2Health News:Blood Transfusion and Outcomes 2Health News:Blood Transfusion and Outcomes 3Health News:Blood Transfusion and Outcomes 4Health News:AcelRx Announces Initiation of Phase 2 Cancer Breakthrough Pain Program 2Health News:Free Manicures & Martinis Hits Chicago and Denver 2Health News:Free Manicures & Martinis Hits Chicago and Denver 3Health News:Eppsteiner and Fiorica and Milstein, Adelman & Kreger Report Lawsuit Certified as Class Action Against Pella Subidiary, Viking Industries 2
... All-in-one procedure drape made of 3M™ Steri-Drape™ ... to create a sterile field during procedures ... quick and convenient by eliminating the need ... of extremity drapes with elastic apertures suitable ...
The Abbott Commander is an automated, high-throughput immunoassay testing system. The Commander System consists of the Flexible Pipetting Center, the Parallel Processing Center, and the Dynamic Incub...
... Abbott m1000 sample preparation platform is an ... and DNA from patient samples using novel ... fully automated sample preparation and is cabable ... hours for a 1 ml sample volume., ...
... CELL-DYN 3700 combines optical light scatter ... Scatter Separation (MAPSS) to fully automate ... improve performance and productivity in critical-care ... revolutionary concept of complementary technologies to ...
Medicine Products: